| The Legacy Rehab & Care Center | |
| 2812 Silver Creek Road, Bullhead City, Arizona 86442 | |
| (928) 763-1404 | |
| Name | The Legacy Rehab & Care Center |
|---|---|
| Location | 2812 Silver Creek Road, Bullhead City, Arizona |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 120 |
| Occupancy Rate | 53% |
| Medicare ID (CCN) | 035097 |
| Legal Business Name | Silver Ridge Management Inc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1306846936 |
| Organization Name | MOHAVE HEALTH CARE |
| Doing Business As | SILVER RIDGE VILLAGE |
| Address | 2812 Silver Creek Rd, Bullhead City, AZ 86442 |
| Phone Number | 928-763-1404 |
News Archive
Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accurately distinguish stem cells that drive aggressive, metastatic breast cancer from other breast cancer cells.
The most recent BioRadar analysis of the virus genomes of both H5N1, known for high lethality, and H1N1, known for high infectivity, indicates that the Replikin Counts of both strains are rising. Such Count increases in a specific strain have been invariably associated with clinical outbreaks of that strain.
Boston Scientific Corporation today announced the U.S. and European launches of the Sterling® SL PTA Balloon Dilatation Catheter, a high-performance balloon dilatation catheter designed for use in peripheral angioplasty procedures below the knee. The Company plans to launch the product immediately in both markets.
Researchers at the Department of Biochemistry and Molecular Biology of Universitat Autònoma de Barcelona (UAB) have revealed the process by which proteins with a tendency to cause conformational diseases such as amyotrophic lateral sclerosis, familial amyloidotic polyneuropathy, familial amyloidotic cardiomyopathy, etc. finally end up causing them.
Avila Therapeutics, Inc. announced today that it has signed a worldwide strategic alliance with sanofi-aventis to discover targeted covalent drugs for the treatment of cancers. Under the alliance agreement sanofi-aventis obtains a worldwide exclusive license to develop and commercialize the compounds resulting from the discovery collaboration.
› Verified 4 days ago
| NPI Number | 1437270634 |
| Organization Name | SILVER RIDGE MANAGEMENT INC |
| Doing Business As | THE LEGACY REHAB & CARE CENTER |
| Address | 2812 Silver Creek Rd, Bullhead City, AZ 86442 |
| Phone Number | 928-763-1404 |
News Archive
Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accurately distinguish stem cells that drive aggressive, metastatic breast cancer from other breast cancer cells.
The most recent BioRadar analysis of the virus genomes of both H5N1, known for high lethality, and H1N1, known for high infectivity, indicates that the Replikin Counts of both strains are rising. Such Count increases in a specific strain have been invariably associated with clinical outbreaks of that strain.
Boston Scientific Corporation today announced the U.S. and European launches of the Sterling® SL PTA Balloon Dilatation Catheter, a high-performance balloon dilatation catheter designed for use in peripheral angioplasty procedures below the knee. The Company plans to launch the product immediately in both markets.
Researchers at the Department of Biochemistry and Molecular Biology of Universitat Autònoma de Barcelona (UAB) have revealed the process by which proteins with a tendency to cause conformational diseases such as amyotrophic lateral sclerosis, familial amyloidotic polyneuropathy, familial amyloidotic cardiomyopathy, etc. finally end up causing them.
Avila Therapeutics, Inc. announced today that it has signed a worldwide strategic alliance with sanofi-aventis to discover targeted covalent drugs for the treatment of cancers. Under the alliance agreement sanofi-aventis obtains a worldwide exclusive license to develop and commercialize the compounds resulting from the discovery collaboration.
› Verified 4 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accurately distinguish stem cells that drive aggressive, metastatic breast cancer from other breast cancer cells.
The most recent BioRadar analysis of the virus genomes of both H5N1, known for high lethality, and H1N1, known for high infectivity, indicates that the Replikin Counts of both strains are rising. Such Count increases in a specific strain have been invariably associated with clinical outbreaks of that strain.
Boston Scientific Corporation today announced the U.S. and European launches of the Sterling® SL PTA Balloon Dilatation Catheter, a high-performance balloon dilatation catheter designed for use in peripheral angioplasty procedures below the knee. The Company plans to launch the product immediately in both markets.
Researchers at the Department of Biochemistry and Molecular Biology of Universitat Autònoma de Barcelona (UAB) have revealed the process by which proteins with a tendency to cause conformational diseases such as amyotrophic lateral sclerosis, familial amyloidotic polyneuropathy, familial amyloidotic cardiomyopathy, etc. finally end up causing them.
Avila Therapeutics, Inc. announced today that it has signed a worldwide strategic alliance with sanofi-aventis to discover targeted covalent drugs for the treatment of cancers. Under the alliance agreement sanofi-aventis obtains a worldwide exclusive license to develop and commercialize the compounds resulting from the discovery collaboration.
› Verified 4 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 25.86 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 9.2 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 56.14 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 8.63 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 4.49 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 4.94 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 0 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 13.41 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 96.64 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.52 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 48.59 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 8.89 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 10.34 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.21 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 57.2 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 91.52 | 82.93 |
News Archive
Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accurately distinguish stem cells that drive aggressive, metastatic breast cancer from other breast cancer cells.
The most recent BioRadar analysis of the virus genomes of both H5N1, known for high lethality, and H1N1, known for high infectivity, indicates that the Replikin Counts of both strains are rising. Such Count increases in a specific strain have been invariably associated with clinical outbreaks of that strain.
Boston Scientific Corporation today announced the U.S. and European launches of the Sterling® SL PTA Balloon Dilatation Catheter, a high-performance balloon dilatation catheter designed for use in peripheral angioplasty procedures below the knee. The Company plans to launch the product immediately in both markets.
Researchers at the Department of Biochemistry and Molecular Biology of Universitat Autònoma de Barcelona (UAB) have revealed the process by which proteins with a tendency to cause conformational diseases such as amyotrophic lateral sclerosis, familial amyloidotic polyneuropathy, familial amyloidotic cardiomyopathy, etc. finally end up causing them.
Avila Therapeutics, Inc. announced today that it has signed a worldwide strategic alliance with sanofi-aventis to discover targeted covalent drugs for the treatment of cancers. Under the alliance agreement sanofi-aventis obtains a worldwide exclusive license to develop and commercialize the compounds resulting from the discovery collaboration.
› Verified 4 days ago
The Legacy Rehab & Care Center Location: 2812 Silver Creek Road, Bullhead City, Arizona 86442 Phone: (928) 763-1404 |